COMP <GO>
BXC vs PG // ENTERPRISE SCALE & MARKET CAP
Bluelinx Holdings Inc. (NYSE) VS. Procter & Gamble Company (NYSE) • 15-METRIC TALLY: BXC 2
— PG 10
▲ ENTERPRISE SCALE & MARKET CAP LEADER: PG
LAST: $79.03 (+0.98%) • MKT CAP: $615.1M
market-cap
$615.1M
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
market-cap
$372.21B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BXC VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BXC | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 15.30% | 51.20% | -35.90 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.90% | 25.40% | -20.50 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 9.5x | 16.2x | -6.70 | BXC | /valuation <GO> |
| Free Cash Flow Yield | 5.34% | 3.77% | +1.57 | BXC | /fcf-yield <GO> |
| Operating Margin | 1.10% | 24.30% | -23.20 | PG | /operating-margins <GO> |
| Net Profit Margin | 0.00% | 19.00% | -19.00 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 0.00% | 0.30% | -0.30 | PG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.44 | 5.59 | -2.15 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | PG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.7 | 60.3 | -4.60 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.87 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 21.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $615.1M | $372.21B | -$371.60B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BXC REV | PG REV | BXC GROSS % | PG GROSS % | BXC FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.95B | $84.28B | 15.3% | 51.2% | $32.9M | $14.04B |
| FY 2024 | $2.95B | $84.04B | 16.6% | 51.4% | $45.1M | $16.52B |
| FY 2023 | $3.14B | $82.01B | — | — | $306.3M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BXC // BETA —
PG // BETA 0.87